
Hans Messner Allogeneic BMT Program
@Hans_BMTProgram
Followers
211
Following
157
Media
29
Statuses
135
Official account of the Hans Messner Allogeneic Blood and Marrow Transplant Program at Princess Margaret Hospital, Toronto. Posts are not medical advice.
Toronto
Joined March 2020
Our multidisciplinary team endeavours to provide the highest standards of care. The overarching theme that drives our efforts are to get patients back to their normal lives by treating their diseases, limiting complications (NRM), and preserving quality of life (GRFS).
1
2
4
RT @nihardesai89: 📢 Now out in @BrJHaem 🎊🎉. Our latest work from the @pmcancercentre explores how GvHD prophylaxis influences the risk of s….
0
16
0
RT @PMCancerEdu: An allogeneic stem cell transplant uses donor stem cells to treat cancer. People who will have an allogeneic stem cell tra….
0
2
0
RT @nihardesai89: 📢 Published in @ASTCT_Journal 🎉. Using a large dataset (@CIBMTR + @Hans_BMTProgram), we show that ATG + PTCy may alleviat….
0
14
0
RT @nihardesai89: 🎉 Out now in @ASTCT_Journal 🙌🏽. We compare two conditioning regimens for second allogeneic transplant after primary graft….
0
17
0
RT @AhmedAlNughmush: Our work is now out in @ASTCT_Journal . We looked into the association between cumulative cyclosporine exposure over t….
0
4
0
RT @Ruah_Mahmoud: Delighted to share our latest publication on the impact of conditioning intensity in younger AML patients receiving dual….
onlinelibrary.wiley.com
Introduction Myeloablative conditioning (MAC) for acute myeloid leukemia (AML) improves disease control by reducing relapse risk but is associated with higher non-relapse mortality (NRM). Reduced-i...
0
6
0
RT @Haemophage: Proud moment at the CTTC Conference!.Here’s a roundup of phenomenal poster presentations from our team at @Hans_BMTProgram….
0
4
0
RT @SergioRdzRdz: 🚨 New Study Alert!.@nihardesai89 @Haemophage @IvanPasic . Our team retrospectively analyzed our cohort on allogeneic HSCT….
0
7
0
RT @nihardesai89: Excellent thread summarising key findings of our latest publication from @pmcancercentre 👇🏽. DM me if you want the PDF 🙌🏽….
0
9
0
RT @nihardesai89: The abstract titles for #ASCO25 are out 🙌🏽. We asked 2 questions:.1. Can we ⤵️the PTCy dose in MUDs?. 2. What's the outco….
0
10
0
RT @pmcancercentre: Exciting news from a dear patient. Thank you for sharing your journey with us.
0
3
0
RT @nihardesai89: 🎉🎉🎉Excited to have TWO ORAL PRESENTATIONS at #ASCO25 in Chicago! . As always, I'm thankful to @Haemophage and the team at….
0
6
0
RT @nihardesai89: 🎉🎉 200 ALLOGENEIC transplants in a year is no mean feat 💪🏽💪🏽💪🏽💪🏽💪🏽💪🏽. I am proud to be a part of this amazing team 💪🏽 . P….
0
8
0
Huge milestone!.Today our centre infused the 200th AlloBMT for this fiscal year. That’s 200 Allogeneic Stem Cell Transplants THIS YEAR (overall we’re >5k) and we’re still going strong! A new record!.#AlloBMT #bmtsm @pmcancercentre @UHN @nihardesai89 @bradwouters @thePMCF
1
4
19
RT @Haemophage: Wow! What a phenomenal team we work with at @Hans_BMTProgram !.It truly takes a village to achieve such a monumental goal.
0
2
0
RT @PMCancerEdu: This eLearning series explains the process of allogeneic stem cell transplant to treat sickle cell disease. .
0
3
0
RT @nihardesai89: I am pleased to present 3 posters and chair a session at @TheEBMT annual meeting in Florence 🙌🏽. Can't wait to meet the m….
0
4
0
RT @PMCancerEdu: An allogeneic stem cell transplant uses donor stem cells to treat cancer. People who will have an allogeneic stem cell tra….
0
2
0
RT @nihardesai89: In 2024, we performed close to 250 allogeneic transplants!!. Thank you to our patients and every member of the exceptiona….
0
8
0